InMed Pharmaceuticals Statistics
NASDAQ: INMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.330.00 (0.00%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
InMed Pharmaceuticals by the numbers
InMed Pharmaceuticals has a market capitalization of $7.3 million based on 5.49M shares outstanding. With trailing EPS of $-2.84, InMed Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.6% below its 50-day average and 12.5% above its 200-day average.
Average daily trading volume is 914.23K shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INM valuation vs. peer median
| Metric | INM | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.31M | $7.41M | -1% |
| Avg. volume | 914.23K | 173.06K | +428% |
Peer median across 8 companies: MDCX, TRAW, SKYE, CURX, SNGX, LGVN, BOLT, APRE.
Valuation
- Market cap
- $7.31M
- EPS (TTM)
- $-2.84
- Shares outstanding
- 5.49M
Price and trading
- Previous close
- 1.33
- Open
- 1.32
- Day range
- 1.32 – 1.36
- 52-week range
- 0.575 – 2.40
- Beta
- —
- Volume
- 26.76K
- Average volume
- 914.23K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 7.31M
- Forward Pe
- -0.21
- Eps
- -2.84
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.40
- Week52 Low
- 0.58
- Avg Volume
- 914.23K
- Shares Outstanding
- 5.49M
- Ma50
- 1.39
- Ma200
- 1.18
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -44.58%
- Pct From52w Low
- 131.30%